We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

172 hedge funds and large institutions have $1.62B invested in Esperion Therapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 41 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 18

64% more capital invested

Capital invested by funds: $991M → $1.62B (+$631M)

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

35% more call options, than puts

Call options by funds: $40.9M | Put options by funds: $30.3M

34% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 41

13% more funds holding

Funds holding: 152172 (+20)

2.42% more ownership

Funds ownership: 99.48%101.9% (+2.4%)

Holders
172
Holders Change
+20
Holders Change %
+13.16%
% of All Funds
3.39%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
45
Increased
55
Reduced
41
Closed
18
Calls
$40.9M
Puts
$30.3M
Net Calls
+$10.6M
Net Calls Change
+$5.12M